PhD Studentship in Targeted Protein Degradation: The University of Dundee’s School of Life Sciences is inviting applications for a funded PhD studentship focused on the investigation of efflux transporter liabilities related to bifunctional degraders in the context of neurodegenerative diseases. This project offers an exciting opportunity to explore innovative therapeutic strategies for conditions such as Alzheimer’s and Parkinson’s disease.
Scholarship Opportunity: Investigating Efflux Transporter Liabilities of Targeted Protein Degraders
Designation
PhD Studentship in Targeted Protein Degradation
Research Area
- Targeted Protein Degradation
- Neurodegenerative Diseases
- Drug Design and Discovery
Location
University of Dundee, School of Life Sciences, Centre for Targeted Protein Degradation
Eligibility/Qualification
- Degree (equivalent of Honours or Masters) in a relevant discipline.
- Open to Home Fee students as determined by the University Fee Status Assessment.
Description
This four-year studentship, funded by the School of Life Sciences, provides tuition fees, training/research costs, and an annual tax-free stipend of £19,236, commencing in September 2025. The successful candidate will investigate how bifunctional degraders can cross the blood-brain barrier and develop design rules to maximize their clinical impact. The project involves collaboration with Promega Corporation and supervision from Dr. William Farnaby and Professor Kevin Read. There will be opportunities to enhance skills in molecular and cellular biology, drug design, and in vitro drug profiling assays, as well as extensive interaction with industry scientists.
How to Apply
Interested applicants should reach out for informal inquiries to Dr. William Farnaby at w.farnaby@dundee.ac.uk. More information can be accessed through the provided links:
Applications must be submitted according to the University of Dundee’s guidelines for postgraduate research programs.
Last Date to Apply
6 December 2024
